Assessment of COVID-19 vaccine hesitancy among undergraduate medical students of a tertiary care teaching hospital, Surat: a source of profound concern

Awani Y. Shah, Neeta Banzal, Chaitali Mehta, Anupama Desai


Background: The discussion around COVID-19 vaccines has been in the limelight ever since the announcement was made for mass vaccination campaign in India. Less is known about undergraduate medical students’ perception and willingness towards getting COVID-19 vaccination. The aim of the study was to assess reasons for the apprehension if present towards taking the COVID-19 vaccines among medical students and to spread awareness about the ongoing issue.

Methods: This was a prospective, cross sectional, survey-based study which was conducted at Surat Municipal Institute of Medical Education and Research (SMIMER), Surat, Gujarat, India. Questionnaire was distributed among medical students during lectures and exam going students were sent Google form link. Data collection was done from February to March 2021, and 550 students submitted the forms.

Results: While 34.9% students had taken the vaccine voluntarily, category I (acceptance group); 18.2% students were initially hesitant to take the vaccine, but later took it, category II (hesitant group); the frequency increased to 46.9% students who are still hesitant and have not taken the vaccine, category III (refusal group). Top reasons for hesitancy were: concern regarding adverse events (69%), safety (60%) and lack of scientific data (27%) provided for the vaccines.

Conclusions: This study revealed that there was lack of knowledge and positive attitude towards the COVID-19 vaccines among the non-vaccinated students. This evaluation has guided the importance and the need of targeted educational program to address the knowledge gap.


COVID-19 vaccines, Undergraduate, Medical students, Hesitancy

Full Text:



Shrivastava S, Shrivastava P. Corona Virus Disease 2019 Pandemic: The Necessity for Outbreak Readiness and Response Plan in Prison Settings. MAMC J Med Sci. 2020;6(2):121.

WHO. Weekly epidemiological update on COVID-19, 2021. Available at: Accessed on 11 May 2021.

Patil P. Fight Against Covid, 2021. Available at: Accessed on 23 May 2021.

Wiot F, Shirley J, Prugnola A, Pasquale A, Philip R. Challenges facing vaccinators in the 21st century: results from a focus group qualitative study. Hum Vaccin Immunother. 2019;15(12):2806-15.

Lucia VC, Kelekar A, Afonso NM. COVID-19 vaccine hesitancy among medical students. J Public Health. 2020;230.

Ministerio De Aseuntos Exteriores De Cooperation. Euromed Survey Of Experts And Actors Violent Extremism In The Euromediterranean Region, 2019. Available at: Accessed on 23 May 2021.

Kvasyuk EN. Development of professional competence of future foreign language teachers in inclusive education through profession-based volunteering. Kvasyuk EN. SHS Web of Conferences. 2020;87:27.

Barello S, Nania T, Dellafiore F, Graffigna G, Caruso R. 'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic. Eur J Epidemiol. 2020;35(8):781-3.

Saied SM, Saied EM, Kabbash IA, Abdo SAE. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J Med Virol. 2021;93(7):4280-91.

Qiao S, Friedman DB, Tam CC, Zeng C, Li X. Vaccine acceptance among college students in South Carolina: Do information sources and trust in information make a difference?. MedRxiv. 2020;20242982.

Betsch C, Wicker S. E-health use, vaccination knowledge and perception of own risk: drivers of vaccination uptake in medical students. Vaccine. 2012;30(6):1143-8.

Stokes DC. Senior Medical Students in the COVID-19 Response: An Opportunity to Be Proactive. Acad Emerg Med. 2020;27(4):343-5.

Sun S, Lin D, Operario D. Interest in COVID-19 vaccine trials participation among young adults in China: Willingness, reasons for hesitancy, and demographic and psychosocial determinants. MedRxiv. 2020;20152678.

Sah R, Shrestha S, Mehta R, Sah SK, Raaban AA, Dharma K, et al. AZD1222 (Covishield) vaccination for COVID-19: Experiences, challenges, and solutions in Nepal. Travel Med Infect Dis. 2021;40:101989.

Bharat Biotech. Bharat Biotech Announces Phase 3 Results of COVAXIN®: India’s First COVID-19 Vaccine Demonstrates Interim Clinical Efficacy of 81%, 2021. Available at: Accessed on 23 May 2021.

Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225-8.